Alerts will be sent to your verified email
Verify Email
SUNPHARMA
|
Sun Pharma Inds.
|
Mankind Pharma
|
Cipla
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
API Sector
|
|||
|
US DMF Filings
|
498.0 . | n/a | 1704.0 . |
|
US DMF Approval
|
385.0 . | n/a | n/a |
|
Pharmaceutical Sector
|
|||
|
Number of ANDA's Filed in USA
|
624.0 . | 55.0 . | 273.0 . |
|
Number of ANDA's Approved By USFDA
|
529.0 . | 32.0 . | 193.0 . |
|
Domestic Sales Growth - YoY
|
10.9 % | n/a | 9.2 % |
|
R&D as a % of Total Sales
|
6.8 % | 2.15 % | 6.1 % |
|
Financials
|
|||
|
5 yr Average ROE
|
8.59 % | 23.48 % | 11.43 % |
|
5yr average Equity Multiplier
|
1.42 | 1.4 | 1.39 |
|
5yr Average Asset Turnover Ratio
|
0.53 | 1.02 | 0.76 |
|
5yr Avg Net Profit Margin
|
11.42 % | 16.52 % | 10.96 % |
|
Price to Book
|
6.1 | 10.36 | 4.5 |
|
P/E
|
40.99 | 50.56 | 30.15 |
|
5yr Avg Cash Conversion Cycle
|
-72.43 Days | -45.92 Days | -3.69 Days |
|
Inventory Days
|
48.56 Days | 60.23 Days | 59.85 Days |
|
Days Receivable
|
53.89 Days | 19.33 Days | 44.13 Days |
|
Days Payable
|
168.32 Days | 132.42 Days | 114.64 Days |
|
5yr Average Interest Coverage Ratio
|
27.62 | 47.23 | 23.71 |
|
5yr Avg ROCE
|
14.84 % | 31.06 % | 15.24 % |
|
5yr Avg Operating Profit Margin
|
26.71 % | 25.32 % | 22.51 % |
|
5 yr average Debt to Equity
|
0.13 | 0.07 | 0.13 |
|
5yr CAGR Net Profit
|
26.03 % | 17.25 % | 12.9 % |
|
5yr Average Return on Assets
|
6.08 % | 16.73 % | 8.36 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
54.48 % | 74.88 % | 33.47 % |
|
Share Pledged by Promoters
|
2.05 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -1.62 % | -3.26 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.28 % | 6.74 % | 2.19 % |
|
Sun Pharma Inds.
|
Mankind Pharma
|
Cipla
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Therapeutic Area Wise Break-Up - Domestic
|
Therapeutic Area Wise Break-Up - Domestic
|
-
|
Therapeutic Area Wise Break-Up - Domestic
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
